A detailed history of Creekside Partners transactions in Johnson & Johnson stock. As of the latest transaction made, Creekside Partners holds 8,086 shares of JNJ stock, worth $1.17 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
8,086
Previous 8,120 0.42%
Holding current value
$1.17 Million
Previous $1.19 Billion 10.41%
% of portfolio
0.68%
Previous 0.66%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$145.48 - $167.38 $4,946 - $5,690
-34 Reduced 0.42%
8,086 $1.31 Billion
Q2 2024

Aug 30, 2024

BUY
$144.38 - $157.78 $1.17 Million - $1.28 Million
8,120 New
8,120 $1.19 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Creekside Partners Portfolio

Follow Creekside Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creekside Partners, based on Form 13F filings with the SEC.

News

Stay updated on Creekside Partners with notifications on news.